ADC Therapeutics S.A.

NYSE:ADCT

Biotechnology

Healthcare
$1.37 -1.35%

-$0.02 today

Market cap
$192.71M
Beta
1.77
P/E (TTM)
-1.2
EPS (TTM)
-$0.89
52W Low $0.78High $4.98

Volume 1.17M

Average 1.68M

Balance Sheet

Inspect the capital base behind the business.

Assets

$323.15M

FY 2025 · Annual

+0.4% YoY

Liabilities

$508.98M

FY 2025 · Annual

-3.0% YoY

Equity

-$185.83M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents466.54M326.44M278.6M250.87M261.34M
Short-term Investments00000
Net Receivables31.06M72.97M25.18M20.32M29.12M
Inventory11.12M12.07M16.18M18.39M4.18M
Other Current Assets1.11M199K5.99M9.45M11.7M
Total Current Assets525.18M434.98M336.29M307.39M306.34M
Property, Plant & Equipment (Net)11.23M10.26M16.13M13.43M1.3M
Goodwill00000
Intangible Assets13.58M14.36M000
Long-term Investments41.24M7.61M1.65M00
Tax Assets26.05M37.1M000
Other Non-current Assets693K(13.46M)711K1.16M15.52M
Total Non-current Assets92.79M55.88M18.49M14.59M16.82M
Total Assets617.97M490.86M354.78M321.98M323.15M
Account Payables12.08M12.35M15.57M18.03M9.18M
Short-term Debt6.58M12.47M003M
Tax Payables3.75M0000
Deferred Revenue00000
Other Current Liabilities14.11M4.08M37.94M47.47M57.99M
Total Current Liabilities73.94M81.94M67.67M80.47M70.16M
Long-term Debt125.1M109.71M112.73M113.63M436.01M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)23.54M23.54M0320.09M0
Other Non-current Liabilities222.32M189.65M312.45M2.43M2.81M
Total Non-current Liabilities377.95M329.47M435.36M444.15M438.82M
Total Liabilities451.88M411.41M503.03M524.62M508.98M
Common Stock6.45M7.31M7.31M8.43M11.08M
Retained Earnings(924.89M)(1.1B)(1.34B)(1.49B)(1.64B)
Accumulated OCI102.83M1.82M(93K)(1.42M)(517K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity166.09M79.45M(148.25M)(202.64M)(185.83M)
Total Debt139.7M129.85M124.38M123M439.01M
Net Debt(326.85M)(196.59M)(154.22M)(127.87M)177.67M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$231.0M
Receivables$31.0M
Inventory$4.8M
Other Current$9.9M
Total Current Assets$276.8M
PP&E (Net)$1.2M
Other Non-current$13.5M
Total Non-current Assets$14.7M
Total Assets$291.5M

Analysis

Selected assets total $291.5M for Latest. The largest visible component is Cash & Equivalents at $231.0M, about 79.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
S-3S-3 filingNov 10, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
8-KCurrent reportNov 4, 2026

How much cash does ADCT have?

ADC Therapeutics S.A. (ADCT) reported $261.34M in cash and equivalents in fiscal 2025.

How much debt does ADCT carry?

ADC Therapeutics S.A. (ADCT) reported $439.01M of total debt, with net debt of $177.67M.